Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates

Neonatology

Volumn 91, Issue 3, 2007, Pages 167-173

  Fayon, Michael ^a,b,c   Tayara, Nawar ^a   Germain, Christine ^d   Choukroun, Marie Luce ^b,c   Dumas De La Roque, Eric ^a,b,c   Chêne, Geneviève ^d   Breilh, Dominique ^e   Marthan, Roger ^b,c   Demarquez, Jean Louis ^a  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Albuterol; Artificial; Child; Infant; Ipratropium; Premature; Respiration; Respiratory function tests

Indexed keywords

IPRATROPIUM BROMIDE; TERBUTALINE;

ABSENCE OF SIDE EFFECTS; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; ENDOTRACHEAL INTUBATION; FEMALE; GESTATIONAL AGE; HUMAN; LUNG COMPLIANCE; LUNG RESISTANCE; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME;

ADMINISTRATION, INHALATION; AIRWAY RESISTANCE; BIRTH WEIGHT; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; IPRATROPIUM; LUNG COMPLIANCE; MALE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TERBUTALINE; TREATMENT OUTCOME;

EID: 33947585485     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000097448     Document Type: Article

References (33)

1. McCray PBJ: Spontaneous contractility of human fetal airway smooth muscle. Am J Respir Cell Mol Biol 1993;8:573-580.
2. Sward-Comunelli SL, Mabry SM, Truog WE, Thibeault DW: Airway muscle in preterm infants: changes during development. J Pediatr 1997;130:570-576.
3. Fayon M, Ben-Jebria A, Elleau C: Human airway smooth muscle responsiveness in neonatal lung specimens. Am J Physiol 1994;267:LI80-LI86.
4. Fisher JT: Airway smooth muscle contraction at birth: in vivo vs. in vitro comparisons to the adult. Can J Physiol Pharmacol 1992;70:590-596.
5. Murphy TM, Mitchell RW, Halayko A, Roach J, Roy L, Kelly EA, Munoz NM, Stephens NL, Leff AR: Effect of maturational changes in myosin content and morphometry on airway smooth muscle contraction. Am J Physiol 1991;260:L471-L480.
6. Sparrow MP, Mitchell HW: Contraction of smooth muscle of pig airway tissues from before birth to maturity. J Appl Physiol 1990;68:468-477.
7. Denis D, Fayon MJ, Berger P, Molimard M, De Lara MT, Roux E, Marthan R: Prolonged moderate hyperoxia induces hyperresponsiveness and airway inflammation in newborn rats. Pediatr Res 2001;50:515-519.
8. Allen J, Zwerdling R, Ehrenkranz R, Gaultier C, Geggel R, Greenough A, Kleinman R, Klijanowicz A, Martinez F, Ozdemir A, Panitch HB Nickerson B, Stein MT, Tomezsko J, Van Der Anker J: Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003;168:356-396.
9. Rotschild A, Solimano A, Puterman M, Smyth J, Sharma A, Albersheim S: Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia. J Pediatr 1989;115:984-991.
10. Denjean A, Paris-Llado J, Zupan V, Debillon T, Kieffer F, Magny JF, Desfreres L, Llanas B, Guimaraes H, Moriette G, Voyer M, Dehan M, Breart G: Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study. Eur J Pediatr 1998;157:926-931.
11. Ng GY, da Silva O, Ohlsson A: Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001:CD003214.
12. Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastel MR: Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996;128:479-484.
13. Shojaei-Brosseau T, Bonaiti-Pellie C, Lyonnet S, Feingold J, Lucet V: Vagal overactivity: a risk factor of sudden infant death syndrome? Arch Dis Child 2003;88:88.
14. Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-534.
15. Choukroun ML, Tayara N, Fayon M, Demarquez JL: Early respiratory system mechanics and the prediction of chronic lung disease in ventilated preterm neonates requiring surfactant treatment. Biol Neonate 2003;83:30-35.
16. Gappa M, Colin AA, Goetz I, Stocks J: Passive respiratory mechanics: the occlusion techniques. Eur Respir J 2001;17:141-148.
17. Fayon M, Tayara N, Choukroun ML, Demarquez JL: Dose of bronchodilators for ventilated neonates. Pediatr Pulmonol 1999;(suppl 18):A243.
18. Shaffer TH, Koen PA, Moskowitz GD, Ferguson JD, Delivoria-Papadopoulos M: Positive end expiratory pressure: effects on lung mechanics of premature lambs. Biol Neonate 1978;34:1-10.
19. Mhanna MJ, Dreshaj IA, Haxhiu MA, Martin JG: Mechanism for substance P-induced relaxation of precontracted airway smooth muscle during development. Am J Physiol Lung Cell Mol Physiol 1999;276:L51-L56.
20. Marty J, Desmonts JM: Effects of fentanyl on respiratory pressure-volume relationship in supine anesthetized children. Acta Anaesthesiol Scand 1981;25:293-296.
21. Fahnenstich H, Steffan J, Kau N, Bartmann P: Fentanyl-induced chest wall rigidity and laryngospasm in preterm and term infants. Crit Care Med 2000;28:836-839.
22. Montravers P, Dureuil B, Desmonts JM: Effects of i.v. midazolam on upper airway resistance. Br J Anaesth 1992;68:27-31.
23. Ng E, Taddio A, Ohlsson A: Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev 2003:CD002052.
24. Bhandari V, Bergqvist LL, Kronsberg SS, Barton BA, Anand KJ: Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics 2005;116:352-359.
25. Gappa M, Gartner M, Poets CF, von der Hardt H: Effects of salbutamol delivery from a metered dose inhaler versus jet nebulizer on dynamic lung mechanics in very preterm infants with chronic lung disease. Pediatr Pulmonol 1997;23:442-448.
26. Fok TF, Monkman S, Dolovich M, Gray S, Coates G, Paes B, Rashid F, Newhouse M, Kirpalani H: Efficiency of aerosol medication delivery from a metered dose inhaler vs. jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21:301-309.
27. Sivakumar D, Bosque E, Goldman SL: Bronchodilator delivered by metered dose inhaler and spacer improves respiratory system compliance more than nebulizer-delivered bronchodilator in ventilated premature infants. Pediatr Pulmonol 1999;27:208-212.
28. Khalaf MN, Hurley JF, Bhandari V: A prospective controlled trial of albuterol aerosol delivered via metered dose inhaler-spacer device (MDI) vs. jet nebulizer in ventilated preterm neonates. Am J Perinatol 2001;18:169-174.
29. Ballard J, Lugo RA, Salyer JW: A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit. Respir Care 2002;47:31-38.
30. Rennard SI: Treatment of stable chronic obstructive pulmonary disease. Lancet 2004;364:791-802.
31. Wilkie RA, Bryan MH: Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr 1987;111:278-282.
32. Lee H, Arnon S, Silverman M: Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1994;70:F218-F222.
33. Brundage KL, Mohsini KG, Froese AB, Fisher JT: Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1990;142:1137-1142.